These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 963828)

  • 1. [Erythromycin stearate Spofa--coated tablets for pediatric practice].
    Havlik J; Holý M
    Cesk Pediatr; 1976 Jul; 31(7):402-4. PubMed ID: 963828
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythromycin pharmacokinetics in children after rectal and oral administration].
    Nazarov AD; Strachunskiĭ LS; Firsov AA; Petrachenkova NA; Sushkova VI; Sheliakina RD; Kagan EZ; Nesterova LIa; Sinitsyna NI
    Antibiot Khimioter; 1991 Feb; 36(2):36-9. PubMed ID: 2025118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and efficacy of erythromycin stearate tablets versus enteric-coated erythromycin base capsules in the treatment of patients with acne vulgaris.
    Bleeker J
    J Int Med Res; 1983; 11(1):38-41. PubMed ID: 6219902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of erythromycin suppositories in pediatric practice].
    Bosco U
    Minerva Pediatr; 1973 Mar; 25(9):401-5. PubMed ID: 4714178
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of intestinal amebiasis using erythromycin stearate of normal release with enteric coating (A-16535). Study of 13 cases. Preliminary report].
    Molina Pasquel C; Hernández y Silva J; Rosas M
    Rev Invest Salud Publica; 1967; 27(4):321-6. PubMed ID: 5618959
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythromycin in acute pharyngitis: a comparison of efficacy and patient tolerance of two twice-daily preparations.
    Guthrie R
    Clin Ther; 1988; 10(5):530-5. PubMed ID: 2856596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of erythromycin and flucloxacillin in the treatment of infected skin lesions in general practice.
    Baig A; Grillage MG; Welch RB
    Br J Clin Pract; 1988 Mar; 42(3):110-5. PubMed ID: 3207571
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics and therapeutic efficacy of erythromycin lactobionate in childhood].
    Scotti L; Felicetta I; Boccazzi A; Borzani M
    Minerva Pediatr; 1987 Dec; 39(23-24):1167-70. PubMed ID: 3451072
    [No Abstract]   [Full Text] [Related]  

  • 9. Absorption of erythromycin stearate and enteric-coated erythromycin base after a single oral dose immediately before breakfast.
    Schreiner A; Digranes A
    Infection; 1984; 12(5):345-8. PubMed ID: 6511088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Release of erythromycin from enteric-coated tablets].
    Chałasińska B; Zakrewski Z
    Acta Pol Pharm; 1985; 42(1):61-7. PubMed ID: 4013800
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of erythromycin administered rectally in children. Controlled study].
    Crosato M; Cattaneo G
    Minerva Pediatr; 1978 Jan; 30(1):79-87. PubMed ID: 345076
    [No Abstract]   [Full Text] [Related]  

  • 12. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.
    Clayton D; Leslie A
    J Int Med Res; 1981; 9(6):470-7. PubMed ID: 7319133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stability of erythromycin stearate in coated tablets during the action of gastric juice in vitro].
    Pospísilová B; Kubes J
    Cesk Farm; 1987 Mar; 36(2):67-72. PubMed ID: 3581192
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective comparison of patient tolerance to enteric-coated vs nonenteric-coated erythromycin.
    Ellsworth AJ; Christensen DB; Volpone-McMahon MT
    J Fam Pract; 1990 Sep; 31(3):265-70. PubMed ID: 2202773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerance and efficiency of erythromycin suppositories used in respiratory infections in ambulatory pediatric practice].
    Rodovalho SF
    Hospital (Rio J); 1968 Jun; 73(6):1947-52. PubMed ID: 5306207
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearate.
    DiSanto AR; Chodos DJ
    Antimicrob Agents Chemother; 1981 Aug; 20(2):190-6. PubMed ID: 7283417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of erythromycin stearate and erythromycin succinate in the treatment of oral infections.
    Owen RC; Kenyon R
    Dent Dig; 1966 Apr; 72(4):166-9. PubMed ID: 5217806
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastrointestinal side effects with erythromycin preparations.
    Carter BL; Woodhead JC; Cole KJ; Milavetz G
    Drug Intell Clin Pharm; 1987 Sep; 21(9):734-8. PubMed ID: 3498618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Children's tablets containing erythromycin and bromine hexine in comparison with dried syrup in respiratory tract infections].
    Sciuk F
    Med Welt; 1973 Mar; 24(11):418-20. PubMed ID: 4701879
    [No Abstract]   [Full Text] [Related]  

  • 20. Absorption of erythromycin. A cross-over study in healthy volunteers.
    Männistö P; Tuomisto J; Räsänen R
    Arzneimittelforschung; 1975 Nov; 25(11):1828-31. PubMed ID: 1106445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.